Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR-Mutated Advanced NSCLC
Original Article
W. Fang, L. Wu, X. Meng, Y. Yao, W. Zuo, W. Yao, Y. Xie, Y. Zhang, J. Cui, Y. Zhang, X. Li, W. Zhuang, J. Fang, Q. Wang, W. Jiang, K. Li, Y. Bai, Y. Luo, F. Ma, Y. Yu, W. Zheng, Z. Liu, B. Yang, R. Ma, Y. Fang, R. Yang, L. Jiang, J. Hu, J. Yang, Y. Diao, X. Jin, J. Ge, Y. Yang, and L. Zhang
N Engl J Med 2026;394:13-26
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.

Facebook
X
LinkedIn
Forward